Jiangxi Dongbang Pharmaceutical Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Jiangxi Dongbang Pharmaceutical General Information

Description

Manufacturer of pharmaceuticals aiming to develop new drugs to benefit patients faster. The company offers quinolone synthetic antibacterial agent, anti-COVID-19 API and intermediates, nicotine, propofol, tiopronin and benzofluorenol.

Contact Information

Website
www.dbpharm.com
Formerly Known As
Dongbang
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Corporate Office
  • Fengxin Industrial Park
  • Fengxin County, Jiangxi
  • China
+86 023 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jiangxi Dongbang Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jiangxi Dongbang Pharmaceutical‘s full profile, request access.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »